Neil Chua

6.4k total citations
62 papers, 1.7k citations indexed

About

Neil Chua is a scholar working on Oncology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Neil Chua has authored 62 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 33 papers in Pathology and Forensic Medicine and 13 papers in Neurology. Recurrent topics in Neil Chua's work include Lymphoma Diagnosis and Treatment (33 papers), CNS Lymphoma Diagnosis and Treatment (13 papers) and Cancer survivorship and care (13 papers). Neil Chua is often cited by papers focused on Lymphoma Diagnosis and Treatment (33 papers), CNS Lymphoma Diagnosis and Treatment (13 papers) and Cancer survivorship and care (13 papers). Neil Chua collaborates with scholars based in Canada, United States and United Kingdom. Neil Chua's co-authors include Tony Reiman, Kerry S. Courneya, Christopher M. Sellar, Margaret L. McNeely, Carolyn J. Peddle‐McIntyre, Christine M. Friedenreich, Clare Stevinson, Sanraj Basi, Greg Dueck and Keith Tankel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Neil Chua

55 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neil Chua Canada 21 1.1k 658 365 280 270 62 1.7k
Thomas Elter Germany 27 820 0.8× 1.1k 1.7× 317 0.9× 1.1k 4.1× 395 1.5× 68 2.4k
Michael Fuchs Germany 29 1.2k 1.2× 1.9k 2.9× 232 0.6× 297 1.1× 672 2.5× 161 2.7k
A. Zander Germany 21 701 0.7× 208 0.3× 207 0.6× 453 1.6× 246 0.9× 44 2.5k
B. W. Hancock United Kingdom 16 487 0.5× 434 0.7× 321 0.9× 203 0.7× 148 0.5× 52 1.3k
Keith A. Betts United States 23 328 0.3× 170 0.3× 104 0.3× 110 0.4× 437 1.6× 129 2.0k
Richard A. Drachtman United States 19 217 0.2× 244 0.4× 159 0.4× 172 0.6× 172 0.6× 69 1.1k
José Carlos Jaime‐Pérez Mexico 25 408 0.4× 168 0.3× 330 0.9× 472 1.7× 141 0.5× 182 2.2k
Peter G. Compton United States 22 332 0.3× 121 0.2× 208 0.6× 133 0.5× 370 1.4× 31 1.8k
Kerri Nottage United States 18 553 0.5× 91 0.1× 1.2k 3.2× 463 1.7× 148 0.5× 36 2.2k
Janine Nuver Netherlands 21 452 0.4× 188 0.3× 313 0.9× 80 0.3× 332 1.2× 70 1.8k

Countries citing papers authored by Neil Chua

Since Specialization
Citations

This map shows the geographic impact of Neil Chua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Chua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Chua more than expected).

Fields of papers citing papers by Neil Chua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Chua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Chua. The network helps show where Neil Chua may publish in the future.

Co-authorship network of co-authors of Neil Chua

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Chua. A scholar is included among the top collaborators of Neil Chua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Chua. Neil Chua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kubrak, Catherine, Lisa Martin, Aaron J. Grossberg, et al.. (2024). Quantifying the severity of sarcopenia in patients with cancer of the head and neck. Clinical Nutrition. 43(4). 989–1000. 11 indexed citations
3.
Puckrin, Robert, Neil Chua, Carolyn Owen, et al.. (2023). Consolidative Autotransplantation Achieves High Cure Rates in Adverse-Risk Large B Cell Lymphoma. Transplantation and Cellular Therapy. 29(12). 763.e1–763.e5.
4.
Puckrin, Robert, et al.. (2022). Favorable Outcomes with R-CHOP Induction and Consolidative Autologous Stem Cell Transplantation for Double-Hit Lymphoma. Transplantation and Cellular Therapy. 28(11). 762.e1–762.e4. 1 indexed citations
5.
Abraham, Aswin, Kurian Joseph, Jennifer L. Spratlin, et al.. (2022). Does Loosening the Inclusion Criteria of the CROSS Trial Impact Outcomes in the Curative-Intent Trimodality Treatment of Oesophageal and Gastroesophageal Cancer Patients?. Clinical Oncology. 34(9). e369–e376. 5 indexed citations
6.
Kostakoglu, Lale, Federico Mattiello, Maurizio Martelli, et al.. (2021). Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study. Haematologica. 107(7). 1633–1642. 37 indexed citations
7.
Pituskin, Edith, et al.. (2020). Therapeutic Ultrasound for Chemotherapy-Related Pain and Sensory Disturbance in the Hands and Feet in Patients With Colorectal Cancer: A Pilot Randomized Controlled Trial. Journal of Pain and Symptom Management. 61(6). 1127–1138. 12 indexed citations
8.
Kubrak, Catherine, Lisa Martin, Leah Gramlich, et al.. (2019). Prevalence and prognostic significance of malnutrition in patients with cancers of the head and neck. Clinical Nutrition. 39(3). 901–909. 63 indexed citations
9.
Kostakoglu, Lale, Maurizio Martelli, Laurie H. Sehn, et al.. (2017). Baseline PET-Derived Metabolic Tumor Volume Metrics Predict Progression-Free and Overall Survival in DLBCL after First-Line Treatment: Results from the Phase 3 GOYA Study. Blood. 130(Suppl_1). 824–824. 20 indexed citations
10.
Peters, Anthea, Tolu Olateju, Jean Deschênes, et al.. (2017). Posttransplant Lymphoproliferative Disorder After Clinical Islet Transplantation: Report of the First Two Cases. American Journal of Transplantation. 17(9). 2474–2480. 5 indexed citations
12.
Pituskin, Edith, Mark J. Haykowsky, Margaret L. McNeely, et al.. (2016). Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN). BMC Cancer. 16(1). 733–733. 37 indexed citations
14.
Harris, Jeffrey, Harold Lau, Neil Chua, et al.. (2014). Health Care Delivery for Head-and-Neck Cancer Patients in Alberta: A Practice Guideline. Current Oncology. 21(5). 704–714. 12 indexed citations
15.
Dueck, Greg, Neil Chua, Daygen L. Finch, et al.. (2014). Final report of a phase 2 clinical trial of lenalidomide monotherapy for patients with T‐cell lymphoma. Cancer. 121(5). 716–723. 76 indexed citations
16.
Courneya, Kerry S., Clare Stevinson, Margaret L. McNeely, et al.. (2011). Effects of Supervised Exercise on Motivational Outcomes and Longer-Term Behavior. Medicine & Science in Sports & Exercise. 44(3). 542–549. 40 indexed citations
17.
Buckstein, Rena, John Kuruvilla, Neil Chua, et al.. (2011). Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials Group. Leukemia & lymphoma. 52(5). 833–841. 14 indexed citations
18.
Mulder, Karen, Andrew Scarfe, Neil Chua, & Jennifer L. Spratlin. (2011). The role of bevacizumab in colorectal cancer: understanding its benefits and limitations. Expert Opinion on Biological Therapy. 11(3). 405–413. 31 indexed citations
19.
Courneya, Kerry S., Clare Stevinson, Margaret L. McNeely, et al.. (2010). Predictors of Adherence to Supervised Exercise in Lymphoma Patients Participating in a Randomized Controlled Trial. Annals of Behavioral Medicine. 40(1). 30–39. 33 indexed citations
20.
Dueck, Greg, Neil Chua, Daygen L. Finch, et al.. (2010). Interim report of a phase 2 clinical trial of lenalidomide for T‐cell non‐Hodgkin lymphoma. Cancer. 116(19). 4541–4548. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026